Intellectual Property Cases
Cases 1 - 10 of 12
RSS Feed | View as table | Sort by last update
Alnylam Pharmaceuticals, Inc. v. Moderna, Inc.
as 23-2357
Plaintiff / Appellant: ALNYLAM PHARMACEUTICALS, INC.
Defendant / Appellee: MODERNA, INC., MODERNATX, INC. and MODERNA US, INC.
Alnylam Pharmaceuticals, Inc. v. Pfizer Inc. et al
as 1:2023cv00578
Plaintiff: Alnylam Pharmaceuticals, Inc.
Defendant: Pfizer Inc. and Pharmacia & Upjohn Co. LLC
Counter Claimant: BioNTech SE and BioNTech Manufacturing GmbH
Cause Of Action: 35 U.S.C. § 271 Patent Infringement
Alnylam Pharmaceuticals, Inc. v. Moderna, Inc. et al
as 1:2023cv00580
Plaintiff: Alnylam Pharmaceuticals, Inc.
Defendant: Moderna, Inc., ModernaTX, Inc. and Moderna US, Inc.
Cause Of Action: 35 U.S.C. § 271 Patent Infringement
Alnylam Pharmaceuticals, Inc. v. Pfizer Inc. et al
as 1:2022cv00924
Plaintiff: Alnylam Pharmaceuticals, Inc.
Defendant: Pfizer Inc., Pharmacia & Upjohn Co. LLC, BioNTech SE and others
Cause Of Action: 35 U.S.C. § 271 Patent Infringement
Alnylam Pharmaceuticals, Inc. v. Moderna, Inc. et al
as 1:2022cv00925
Plaintiff: Alnylam Pharmaceuticals, Inc.
Defendant: Moderna, Inc., ModernaTX, Inc. and Moderna US, Inc.
Cause Of Action: 35 U.S.C. § 271 Patent Infringement
Alnylam Pharmaceuticals, Inc. v. Pfizer Inc., et al
as 1:2022cv00336
Plaintiff: Alnylam Pharmaceuticals, Inc.
Defendant: Pfizer Inc. and Pharmacia & Upjohn Co. LLC
Cause Of Action: 35 U.S.C. § 271 Patent Infringement
Alnylam Pharmaceuticals, Inc. v. Moderna, Inc., et al
as 1:2022cv00335
Plaintiff: Alnylam Pharmaceuticals, Inc.
Defendant: Moderna, Inc., ModernaTX, Inc. and Moderna US, Inc.
Cause Of Action: 35 U.S.C. § 271 Patent Infringement
Alnylam Pharmaceuticals, Inc. v. Silence Therapeutics GmbH et al
as 1:2018cv10613
Plaintiff: Alnylam Pharmaceuticals, Inc.
Defendant: Silence Therapeutics GmbH and Silence Therapeutics plc
Cause Of Action: 28 U.S.C. § 2201
Alnylam Pharmaceuticals, Inc. v. Silence Therapeutics plc et al
as 1:2018cv10612
Plaintiff: Alnylam Pharmaceuticals, Inc.
Defendant: Silence Therapeutics plc and Silence Therapeutics GmbH
Cause Of Action: 28 U.S.C. § 2201 Declaratory Judgment
Alnylam Pharmaceuticals, Inc. et al V. Tekmira Pharmaceuticals Corporation We have downloadable decisions or orders for this case
as 1:2012cv10087
Plaintiff: Alnylam Pharmaceuticals, Inc. and Isis Pharmaceuticals Inc.
Defendant: Tekmira Pharmaceuticals Corporation
Cause Of Action: 15 U.S.C. § 1126

Disclaimer: Justia Dockets & Filings provides public litigation records from the federal appellate and district courts. These filings and docket sheets should not be considered findings of fact or liability, nor do they necessarily reflect the view of Justia.

Why Is My Information Online?